![Thomas Folinsbee](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: - $ al 31/03/2026
Thomas Folinsbee currently works at Shanghai Alebund Pharmaceuticals Ltd., as Director-Business Development from 2019 and CASI Pharmaceuticals, Inc., as Independent Director from 2023.
Mr. Folinsbee also formerly worked at 3SBio, Inc., as Director-Corporate Development from 2009 to 2019, Hisanaga Seisakusho Co. Ltd., as Director from 2011 to 2016, Bison Capital Acquisition Corp., as Independent Director from 2017 to 2019, Xynomic Pharmaceuticals Holdings, Inc., as Independent Director, and Summit Healthcare Acquisition Corp., as Independent Director.
Mr. Folinsbee received his undergraduate degree in 1990 from McGill University.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 30/04/2026 | 0 ( -.--% ) | - $ | 31/03/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| CASI PHARMACEUTICALS, INC. | Director/Miembro de la Junta | 21/03/2023 |
Shanghai Alebund Pharmaceuticals Ltd. | Corporate Officer/Principal | 01/01/2019 |
| Empresas | Cargo | Fin |
|---|---|---|
Bison Capital Acquisition Corp.
 Bison Capital Acquisition Corp. Financial ConglomeratesFinance Operates as blank check company | Director/Miembro de la Junta | 01/01/2019 |
| 3SBIO INC. | Corporate Officer/Principal | 01/01/2019 |
Hisanaga Seisakusho Co. Ltd. | Director/Miembro de la Junta | 01/01/2016 |
| SUMT HEAL | Director/Miembro de la Junta | - |
| XYNOMIC PHARMACEUTICALS HOLDINGS, INC. | Director/Miembro de la Junta | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 8 |
|---|---|
3SBio, Inc.
 3SBio, Inc. BiotechnologyHealth Technology Engages in research, development, manufacturing and marketing of biopharmaceutical products | Health Technology |
McGill University
 McGill University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Hisanaga Seisakusho Co. Ltd. | |
Bison Capital Acquisition Corp.
Bison Capital Acquisition Corp. Financial ConglomeratesFinance Operates as blank check company | Finance |
Xynomic Pharmaceuticals Holdings, Inc.
 Xynomic Pharmaceuticals Holdings, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops and supplies oncology drugs | Health Technology |
Summit Healthcare Acquisition Corp.
 Summit Healthcare Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
Shanghai Alebund Pharmaceuticals Ltd. | |
CASI Pharmaceuticals, Inc.
 CASI Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics and pharmaceutical products | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
